Details of the Drug Combinations

General Information of This Drug (ID: DMHL7OB)

Drug Name
Uracil mustard   DMHL7OB
Synonyms
Chlorethaminacil; Demethyldopan; Desmethyldopan; Nordopan; Uracillost; Uracilmostaza; Uramustin; Uramustina; Uramustine; Uramustinum; Aminouracil mustard; Uracil lost; Uracil lost [German]; Uracil mustard [USAN]; Uracil nitrogen mustard; ENT 50439; U 8344; CB-4835; SK-19849; U-8344; Uracil mustard (TN); Uracil mustard (USAN); Uramustina [INN-Spanish]; Uramustine (INN); Uramustinum [INN-Latin]; URACIL MUSTARD (500 MG) (FOR U.S. SALE ONLY); 2,6-Dihydroxy-5-bis(2-chloroethyl)aminopyrimidine; 2,6-Dihydroxy-5-bis[2-chloroethyl]aminopyrimidine; 5-(Bis(2-chlorethyl)amino)-2,4(1H,3H)pyrimidinedione; 5-(Bis(2-chloroethyl)amino)-2,4(1H,3H)pyrimidinedione; 5-(Bis(2-chloroethyl)amino)-2,4-(1H,3H)pyrimidinedione; 5-(Bis(2-chloroethyl)amino)uracil; 5-(Di-(beta-chloroethyl)amino)uracil; 5-(Di-2-chloroethyl)aminouracil; 5-Aminouracil mustard; 5-N,N-Bis(2-chloroethyl)aminouracil; 5-[Bis(2-chlorethyl)amino]-2,4(1H,3H)pyrimidinedione; 5-[Bis(2-chloroethyl)amino]uracil; 5-[Di(2-chloroethyl)amino]uracil; 5-[Di(beta-chloroethyl)amino]uracil; 5-[Di(beta.-chloroethyl)amino]uracil; 5-[bis(2-chloroethyl)amino]-1H-pyrimidine-2,4-dione; 5-[bis(2-chloroethyl)amino]-2,4(1H,3H)-pyrimidinedione; 5-[bis(2-chloroethyl)amino]pyrimidine-2,4(1H,3H)-dione; 5-[bis(2-chloroethyl)amino]pyrimidine-2,4-diol
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Approved [1]
Chronic myelogenous leukaemia 2A20.0 Approved [2]
Polycythemia vera 2A20.4 Approved [2]
Small lymphocytic lymphoma 2A82.0 Approved [2]
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

642 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Uracil mustard DCA9LYN ABIRATERONE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
ABIRATERONE + Uracil mustard DCYTEU1 ABIRATERONE Astrocytoma (Cell Line: SNB-19) [3]
ABIRATERONE + Uracil mustard DCV7CVY ABIRATERONE Chronic myelogenous leukemia (Cell Line: K-562) [3]
ABIRATERONE + Uracil mustard DC1BUQT ABIRATERONE Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
ABIRATERONE + Uracil mustard DC9I1OL ABIRATERONE Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
ABIRATERONE + Uracil mustard DCNK2AY ABIRATERONE Glioma (Cell Line: SF-295) [3]
ABIRATERONE + Uracil mustard DC60KCI ABIRATERONE Plasma cell myeloma (Cell Line: RPMI-8226) [3]
ABIRATERONE + Uracil mustard DCSMOYD ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [3]
ABIRATERONE + Uracil mustard DC3EVNE ABIRATERONE Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
ABIRATERONE + Uracil mustard DCAPZRN ABIRATERONE Carcinoma (Cell Line: MCF7) [4]
ABIRATERONE + Uracil mustard DCF3SXR ABIRATERONE Colon carcinoma (Cell Line: KM12) [4]
ABIRATERONE + Uracil mustard DCRFAJW ABIRATERONE Adenocarcinoma (Cell Line: HCT-15) [5]
ABIRATERONE + Uracil mustard DCPOZAB ABIRATERONE Adenocarcinoma (Cell Line: HCT116) [5]
ABIRATERONE + Uracil mustard DC3IMSZ ABIRATERONE High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
ABIRATERONE + Uracil mustard DCI0YQB ABIRATERONE Lung adenocarcinoma (Cell Line: NCI-H522) [5]
ABIRATERONE + Uracil mustard DCJ34B6 ABIRATERONE Melanoma (Cell Line: SK-MEL-2) [5]
ABIRATERONE + Uracil mustard DCHRFDT ABIRATERONE Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Amonafide + Uracil mustard DC6SA21 Amonafide Adenocarcinoma (Cell Line: OVCAR3) [3]
Amonafide + Uracil mustard DCUF41O Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Amonafide + Uracil mustard DC8LWD8 Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Amonafide + Uracil mustard DCVUYYC Amonafide Astrocytoma (Cell Line: SNB-19) [3]
Amonafide + Uracil mustard DCMI4OD Amonafide Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Amonafide + Uracil mustard DCHB574 Amonafide Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Amonafide + Uracil mustard DCM681M Amonafide Glioblastoma (Cell Line: SNB-75) [3]
Amonafide + Uracil mustard DCDOFHS Amonafide Glioma (Cell Line: SF-268) [3]
Amonafide + Uracil mustard DCG8T8J Amonafide Glioma (Cell Line: SF-295) [3]
Amonafide + Uracil mustard DCHY6KH Amonafide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Amonafide + Uracil mustard DCS32UT Amonafide High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Amonafide + Uracil mustard DCMEXZP Amonafide Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Amonafide + Uracil mustard DC2YSTF Amonafide Lung adenocarcinoma (Cell Line: HOP-62) [3]
Amonafide + Uracil mustard DCXPP7O Amonafide Malignant melanoma (Cell Line: LOX IMVI) [3]
Amonafide + Uracil mustard DCS7NVV Amonafide Melanoma (Cell Line: SK-MEL-2) [3]
Amonafide + Uracil mustard DCQHAWJ Amonafide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Amonafide + Uracil mustard DCZ3N1U Amonafide Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Amonafide + Uracil mustard DCDFJ89 Amonafide Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Amonafide + Uracil mustard DCMX3US Amonafide Prostate carcinoma (Cell Line: PC-3) [3]
Amonafide + Uracil mustard DC2OJOQ Amonafide Colon adenocarcinoma (Cell Line: COLO 205) [4]
Amonafide + Uracil mustard DCYEYNI Amonafide Colon carcinoma (Cell Line: KM12) [4]
Amonafide + Uracil mustard DC4QF8Q Amonafide Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Anastrozole + Uracil mustard DC3LEMU Anastrozole Adenocarcinoma (Cell Line: NCIH23) [3]
Anastrozole + Uracil mustard DCVQB8O Anastrozole Adenocarcinoma (Cell Line: A549) [3]
Anastrozole + Uracil mustard DC545GU Anastrozole Adenocarcinoma (Cell Line: HCT116) [3]
Anastrozole + Uracil mustard DCFQTZU Anastrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Anastrozole + Uracil mustard DCNJL0J Anastrozole Anaplastic large cell lymphoma (Cell Line: SR) [3]
Anastrozole + Uracil mustard DCHW8YW Anastrozole Astrocytoma (Cell Line: U251) [3]
Anastrozole + Uracil mustard DCZTJRL Anastrozole Astrocytoma (Cell Line: SNB-19) [3]
Anastrozole + Uracil mustard DCNSRPB Anastrozole Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Uracil mustard DCFG5PJ Anastrozole Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Uracil mustard DCSYQDF Anastrozole Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Anastrozole + Uracil mustard DCNADW8 Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Anastrozole + Uracil mustard DC4HPP3 Anastrozole Glioma (Cell Line: SF-268) [3]
Anastrozole + Uracil mustard DCDD9JP Anastrozole Glioma (Cell Line: SF-295) [3]
Anastrozole + Uracil mustard DCIFYW7 Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Uracil mustard DCBK06W Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Anastrozole + Uracil mustard DC3K006 Anastrozole Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Uracil mustard DC2OEW9 Anastrozole Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Uracil mustard DCMSRPM Anastrozole Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Anastrozole + Uracil mustard DC9232A Anastrozole Malignant melanoma (Cell Line: UACC62) [3]
Anastrozole + Uracil mustard DCX9A1W Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [3]
Anastrozole + Uracil mustard DCA47NA Anastrozole Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Uracil mustard DCHZ344 Anastrozole Melanoma (Cell Line: MALME-3M) [3]
Anastrozole + Uracil mustard DCYUYP4 Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Uracil mustard DCYVQW4 Anastrozole Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Anastrozole + Uracil mustard DCAMKLC Anastrozole Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Anastrozole + Uracil mustard DCTPS00 Anastrozole Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Uracil mustard DCVJKBU Anastrozole Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Uracil mustard DC90XBP Anastrozole Carcinoma (Cell Line: RXF 393) [4]
Anastrozole + Uracil mustard DC7NM1L Anastrozole Colon carcinoma (Cell Line: KM12) [4]
Anastrozole + Uracil mustard DC31EML Anastrozole Invasive ductal carcinoma (Cell Line: T-47D) [4]
BIO-300 + Uracil mustard DCTC2AV BIO-300 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
BIO-300 + Uracil mustard DCO9IG7 BIO-300 Anaplastic large cell lymphoma (Cell Line: SR) [3]
BIO-300 + Uracil mustard DCRT120 BIO-300 Astrocytoma (Cell Line: SNB-19) [3]
BIO-300 + Uracil mustard DCK1Z0P BIO-300 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
BIO-300 + Uracil mustard DCSM05I BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [3]
BIO-300 + Uracil mustard DC2WOTU BIO-300 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
BIO-300 + Uracil mustard DCD36IE BIO-300 Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
BIO-300 + Uracil mustard DCM8K3V BIO-300 Glioblastoma (Cell Line: SNB-75) [3]
BIO-300 + Uracil mustard DC69TJ3 BIO-300 Glioma (Cell Line: SF-295) [3]
BIO-300 + Uracil mustard DCHX2HL BIO-300 Glioma (Cell Line: SF-268) [3]
BIO-300 + Uracil mustard DCUMYID BIO-300 Glioma (Cell Line: SF-539) [3]
BIO-300 + Uracil mustard DC8CIB0 BIO-300 Papillary renal cell carcinoma (Cell Line: ACHN) [3]
BIO-300 + Uracil mustard DCMNLLX BIO-300 Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
BIO-300 + Uracil mustard DCNY6M6 BIO-300 Carcinoma (Cell Line: RXF 393) [4]
BIO-300 + Uracil mustard DCG3C0E BIO-300 Colon adenocarcinoma (Cell Line: COLO 205) [4]
BIO-300 + Uracil mustard DC88QBP BIO-300 Colon carcinoma (Cell Line: KM12) [4]
BIO-300 + Uracil mustard DCQEZGP BIO-300 Invasive ductal carcinoma (Cell Line: HS 578T) [4]
BIO-300 + Uracil mustard DCNWRYK BIO-300 Adenocarcinoma (Cell Line: HT29) [5]
BIO-300 + Uracil mustard DCHFU0K BIO-300 Adenocarcinoma (Cell Line: HCT116) [5]
BIO-300 + Uracil mustard DCJD0ZV BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
BIO-300 + Uracil mustard DCGOJZY BIO-300 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
BIO-300 + Uracil mustard DC2XQ4V BIO-300 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
BIO-300 + Uracil mustard DC02LQJ BIO-300 Lung adenocarcinoma (Cell Line: HOP-62) [5]
BIO-300 + Uracil mustard DC5UODE BIO-300 Lung adenocarcinoma (Cell Line: EKVX) [5]
BIO-300 + Uracil mustard DCNMFBQ BIO-300 Malignant melanoma (Cell Line: LOX IMVI) [5]
BIO-300 + Uracil mustard DC2V4N8 BIO-300 Malignant melanoma (Cell Line: UACC62) [5]
BIO-300 + Uracil mustard DCDRQ84 BIO-300 Melanoma (Cell Line: SK-MEL-2) [5]
BIO-300 + Uracil mustard DCOL82I BIO-300 Melanoma (Cell Line: UACC-257) [5]
BIO-300 + Uracil mustard DC89RYT BIO-300 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
BIO-300 + Uracil mustard DCFMH6V BIO-300 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
BIO-300 + Uracil mustard DC5FV8H BIO-300 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
BIO-300 + Uracil mustard DCPYXFO BIO-300 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Bleomycin + Uracil mustard DCFF1EH Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Uracil mustard DC2YRC3 Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Bleomycin + Uracil mustard DCEZYR5 Bleomycin Astrocytoma (Cell Line: U251) [3]
Bleomycin + Uracil mustard DC9INEL Bleomycin Astrocytoma (Cell Line: SNB-19) [3]
Bleomycin + Uracil mustard DCHCP3N Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Bleomycin + Uracil mustard DCOP4FF Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bleomycin + Uracil mustard DC9NJFZ Bleomycin Glioblastoma (Cell Line: SNB-75) [3]
Bleomycin + Uracil mustard DC4LYNC Bleomycin Glioma (Cell Line: SF-539) [3]
Bleomycin + Uracil mustard DCE0ZJZ Bleomycin Glioma (Cell Line: SF-295) [3]
Bleomycin + Uracil mustard DCENRGM Bleomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Bleomycin + Uracil mustard DC6AAQV Bleomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Bleomycin + Uracil mustard DC77FPJ Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Bleomycin + Uracil mustard DCXUUKN Bleomycin Carcinoma (Cell Line: RXF 393) [4]
Bleomycin + Uracil mustard DC8PPA7 Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Bleomycin + Uracil mustard DC430AW Bleomycin Colon carcinoma (Cell Line: KM12) [4]
Bleomycin + Uracil mustard DCEE2QX Bleomycin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Bleomycin + Uracil mustard DCI0RQA Bleomycin Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Uracil mustard DCWW4N3 Bleomycin Adenocarcinoma (Cell Line: NCIH23) [5]
Bleomycin + Uracil mustard DCE920K Bleomycin Adenocarcinoma (Cell Line: HCT116) [5]
Bleomycin + Uracil mustard DCQZMNA Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Bleomycin + Uracil mustard DCBJW3T Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Bleomycin + Uracil mustard DC8MU0O Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bleomycin + Uracil mustard DC25QBO Bleomycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Bleomycin + Uracil mustard DCEKZ6G Bleomycin Lung adenocarcinoma (Cell Line: EKVX) [5]
Bleomycin + Uracil mustard DCSBNSY Bleomycin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Bleomycin + Uracil mustard DCWGS9Q Bleomycin Malignant melanoma (Cell Line: UACC62) [5]
Bleomycin + Uracil mustard DCPAVB9 Bleomycin Malignant melanoma (Cell Line: LOX IMVI) [5]
Bleomycin + Uracil mustard DCKKDUQ Bleomycin Melanoma (Cell Line: SK-MEL-2) [5]
Bleomycin + Uracil mustard DCPQ7VI Bleomycin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Bleomycin + Uracil mustard DCS83AS Bleomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Bleomycin + Uracil mustard DC8FL72 Bleomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Bleomycin + Uracil mustard DCOMKZB Bleomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Bleomycin + Uracil mustard DCAQUUS Bleomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Cabazitaxel + Uracil mustard DC92Z5J Cabazitaxel Adenocarcinoma (Cell Line: A549) [3]
Cabazitaxel + Uracil mustard DCFR5BZ Cabazitaxel Adenocarcinoma (Cell Line: HCT116) [3]
Cabazitaxel + Uracil mustard DCR3D0Y Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [3]
Cabazitaxel + Uracil mustard DCFN6DO Cabazitaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Cabazitaxel + Uracil mustard DC9I1D2 Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Cabazitaxel + Uracil mustard DCOGUGZ Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [3]
Cabazitaxel + Uracil mustard DCHD984 Cabazitaxel Astrocytoma (Cell Line: SNB-19) [3]
Cabazitaxel + Uracil mustard DC0IYWJ Cabazitaxel Clear cell renal cell carcinoma (Cell Line: A498) [3]
Cabazitaxel + Uracil mustard DCZX6JK Cabazitaxel Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Cabazitaxel + Uracil mustard DCA2Y1M Cabazitaxel Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Cabazitaxel + Uracil mustard DCU2BY5 Cabazitaxel Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Cabazitaxel + Uracil mustard DCJG7W0 Cabazitaxel Glioblastoma (Cell Line: SNB-75) [3]
Cabazitaxel + Uracil mustard DCB031S Cabazitaxel Glioma (Cell Line: SF-295) [3]
Cabazitaxel + Uracil mustard DC4Q36A Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Cabazitaxel + Uracil mustard DCD68U0 Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Cabazitaxel + Uracil mustard DC6WSFQ Cabazitaxel Lung adenocarcinoma (Cell Line: HOP-62) [3]
Cabazitaxel + Uracil mustard DC4UFKO Cabazitaxel Lung adenocarcinoma (Cell Line: EKVX) [3]
Cabazitaxel + Uracil mustard DCK73HK Cabazitaxel Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Cabazitaxel + Uracil mustard DCA3GKP Cabazitaxel Melanoma (Cell Line: SK-MEL-2) [3]
Cabazitaxel + Uracil mustard DCDTEVZ Cabazitaxel Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Cabazitaxel + Uracil mustard DCG5LSJ Cabazitaxel Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Cabazitaxel + Uracil mustard DCSDUI4 Cabazitaxel Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Cabazitaxel + Uracil mustard DCRR3BY Cabazitaxel Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Cabazitaxel + Uracil mustard DC8MI7J Cabazitaxel Prostate carcinoma (Cell Line: PC-3) [3]
Cabazitaxel + Uracil mustard DCMUCUX Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [3]
Cabazitaxel + Uracil mustard DCSQJ6O Cabazitaxel Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Cabazitaxel + Uracil mustard DCHZFH1 Cabazitaxel Carcinoma (Cell Line: RXF 393) [4]
Cabazitaxel + Uracil mustard DCKVE2U Cabazitaxel Carcinoma (Cell Line: MCF7) [4]
Cabazitaxel + Uracil mustard DCY22JJ Cabazitaxel Colon carcinoma (Cell Line: KM12) [4]
Cabazitaxel + Uracil mustard DC49E4L Cabazitaxel Invasive ductal carcinoma (Cell Line: BT-549) [4]
Crizotinib + Uracil mustard DCKX5GQ Crizotinib Adenocarcinoma (Cell Line: DU-145) [3]
Crizotinib + Uracil mustard DCC5PPK Crizotinib Adenocarcinoma (Cell Line: NCIH23) [3]
Crizotinib + Uracil mustard DCJW3D1 Crizotinib Adenocarcinoma (Cell Line: HCC-2998) [3]
Crizotinib + Uracil mustard DCEXTKY Crizotinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Crizotinib + Uracil mustard DCUM9V9 Crizotinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Crizotinib + Uracil mustard DCPWPDP Crizotinib Astrocytoma (Cell Line: SNB-19) [3]
Crizotinib + Uracil mustard DC54TVH Crizotinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Crizotinib + Uracil mustard DCRXO5U Crizotinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Crizotinib + Uracil mustard DCO90FX Crizotinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Crizotinib + Uracil mustard DC4TG70 Crizotinib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Crizotinib + Uracil mustard DCL5XN2 Crizotinib Glioblastoma (Cell Line: SNB-75) [3]
Crizotinib + Uracil mustard DC9M2Z9 Crizotinib Glioma (Cell Line: SF-295) [3]
Crizotinib + Uracil mustard DCPSA9N Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Crizotinib + Uracil mustard DC8Q80N Crizotinib Lung adenocarcinoma (Cell Line: EKVX) [3]
Crizotinib + Uracil mustard DCQ0R01 Crizotinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Crizotinib + Uracil mustard DCDD2C9 Crizotinib Malignant melanoma (Cell Line: UACC62) [3]
Crizotinib + Uracil mustard DC1O5W0 Crizotinib Melanoma (Cell Line: SK-MEL-2) [3]
Crizotinib + Uracil mustard DC5T1U4 Crizotinib Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Crizotinib + Uracil mustard DC966T8 Crizotinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Crizotinib + Uracil mustard DCY4YAE Crizotinib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Crizotinib + Uracil mustard DCSE46B Crizotinib Renal cell carcinoma (Cell Line: SN12C) [3]
Crizotinib + Uracil mustard DCHXK0H Crizotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Crizotinib + Uracil mustard DCJIR7Y Crizotinib Colon carcinoma (Cell Line: KM12) [4]
Dexrazoxane + Uracil mustard DCIGWQD Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dexrazoxane + Uracil mustard DCUH479 Dexrazoxane Anaplastic large cell lymphoma (Cell Line: SR) [3]
Dexrazoxane + Uracil mustard DCANKH6 Dexrazoxane Astrocytoma (Cell Line: SNB-19) [3]
Dexrazoxane + Uracil mustard DCH589E Dexrazoxane Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dexrazoxane + Uracil mustard DC7DS9X Dexrazoxane Clear cell renal cell carcinoma (Cell Line: A498) [3]
Dexrazoxane + Uracil mustard DCRKKXC Dexrazoxane Glioblastoma (Cell Line: SNB-75) [3]
Dexrazoxane + Uracil mustard DCH4UL3 Dexrazoxane Glioma (Cell Line: SF-295) [3]
Dexrazoxane + Uracil mustard DCKSJL9 Dexrazoxane Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Dexrazoxane + Uracil mustard DC9ATAS Dexrazoxane Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Dexrazoxane + Uracil mustard DCVU73Y Dexrazoxane Colon adenocarcinoma (Cell Line: COLO 205) [4]
Dexrazoxane + Uracil mustard DCMMWBR Dexrazoxane Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dexrazoxane + Uracil mustard DCKF60B Dexrazoxane Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Dexrazoxane + Uracil mustard DC05J8I Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Dexrazoxane + Uracil mustard DCX9UWS Dexrazoxane Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Epirubicin + Uracil mustard DCOKQUD Epirubicin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Epirubicin + Uracil mustard DC273K8 Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Epirubicin + Uracil mustard DCCXO47 Epirubicin Glioma (Cell Line: SF-295) [3]
Epirubicin + Uracil mustard DCHRSPZ Epirubicin Carcinoma (Cell Line: RXF 393) [4]
Epirubicin + Uracil mustard DCAWD9H Epirubicin Lung adenocarcinoma (Cell Line: HOP-62) [5]
Gefitinib + Uracil mustard DCO9SRB Gefitinib Adenocarcinoma (Cell Line: A549) [3]
Gefitinib + Uracil mustard DCI12KL Gefitinib Adenocarcinoma (Cell Line: NCIH23) [3]
Gefitinib + Uracil mustard DCKLGJI Gefitinib Adenocarcinoma (Cell Line: HT29) [3]
Gefitinib + Uracil mustard DCEJ1BF Gefitinib Adenocarcinoma (Cell Line: HCT116) [3]
Gefitinib + Uracil mustard DCQVE4Q Gefitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Gefitinib + Uracil mustard DCI332T Gefitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Gefitinib + Uracil mustard DC1VFH2 Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Gefitinib + Uracil mustard DCTM0NU Gefitinib Astrocytoma (Cell Line: U251) [3]
Gefitinib + Uracil mustard DC6QE7C Gefitinib Astrocytoma (Cell Line: SNB-19) [3]
Gefitinib + Uracil mustard DC7L674 Gefitinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Gefitinib + Uracil mustard DCJW34S Gefitinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Gefitinib + Uracil mustard DCELVZB Gefitinib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Gefitinib + Uracil mustard DCKUF0S Gefitinib Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Gefitinib + Uracil mustard DC25QYN Gefitinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Gefitinib + Uracil mustard DCU0LI5 Gefitinib Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
Gefitinib + Uracil mustard DCXEGJW Gefitinib Glioblastoma (Cell Line: SNB-75) [3]
Gefitinib + Uracil mustard DCCW0H5 Gefitinib Glioma (Cell Line: SF-295) [3]
Gefitinib + Uracil mustard DCMODLL Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Gefitinib + Uracil mustard DCI0C2T Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Gefitinib + Uracil mustard DCCWRUE Gefitinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Gefitinib + Uracil mustard DCZXW9K Gefitinib Lung adenocarcinoma (Cell Line: EKVX) [3]
Gefitinib + Uracil mustard DC74O69 Gefitinib Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Gefitinib + Uracil mustard DC16VR9 Gefitinib Malignant melanoma (Cell Line: LOX IMVI) [3]
Gefitinib + Uracil mustard DCZP4HM Gefitinib Malignant melanoma (Cell Line: UACC62) [3]
Gefitinib + Uracil mustard DC80C21 Gefitinib Melanoma (Cell Line: SK-MEL-2) [3]
Gefitinib + Uracil mustard DCUFGPA Gefitinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [3]
Gefitinib + Uracil mustard DC20TOV Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Gefitinib + Uracil mustard DCBY87K Gefitinib Non-small cell lung carcinoma (Cell Line: HOP-92) [3]
Gefitinib + Uracil mustard DCZXPS9 Gefitinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Gefitinib + Uracil mustard DCVJFE0 Gefitinib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Gefitinib + Uracil mustard DCD5MI5 Gefitinib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Gefitinib + Uracil mustard DCIVUF3 Gefitinib Prostate carcinoma (Cell Line: PC-3) [3]
Gefitinib + Uracil mustard DC3YLX6 Gefitinib Renal cell carcinoma (Cell Line: UO-31) [3]
Gefitinib + Uracil mustard DCH3PRA Gefitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Gefitinib + Uracil mustard DCU3LF0 Gefitinib Colon carcinoma (Cell Line: KM12) [4]
Indazole derivative 5 + Uracil mustard DCQ3Y10 Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Indazole derivative 5 + Uracil mustard DC5U3NI Indazole derivative 5 Astrocytoma (Cell Line: SNB-19) [3]
Indazole derivative 5 + Uracil mustard DCSH966 Indazole derivative 5 Chronic myelogenous leukemia (Cell Line: K-562) [3]
Indazole derivative 5 + Uracil mustard DC5IAIX Indazole derivative 5 Glioblastoma (Cell Line: SNB-75) [3]
Indazole derivative 5 + Uracil mustard DCW50SF Indazole derivative 5 Glioma (Cell Line: SF-295) [3]
Indazole derivative 5 + Uracil mustard DCTVD7G Indazole derivative 5 Colon carcinoma (Cell Line: KM12) [4]
Indazole derivative 5 + Uracil mustard DCQJXKW Indazole derivative 5 Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Indazole derivative 5 + Uracil mustard DCE9XTK Indazole derivative 5 Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Indazole derivative 5 + Uracil mustard DCXM1F4 Indazole derivative 5 Lung adenocarcinoma (Cell Line: EKVX) [5]
Indazole derivative 5 + Uracil mustard DCIYHHR Indazole derivative 5 Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Indazole derivative 5 + Uracil mustard DCSWWEM Indazole derivative 5 Malignant melanoma (Cell Line: UACC62) [5]
Lenalidomide + Uracil mustard DCSWOZQ Lenalidomide Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Lenalidomide + Uracil mustard DCXMVRX Lenalidomide Glioma (Cell Line: SF-295) [3]
Lenalidomide + Uracil mustard DCWDXGL Lenalidomide Invasive ductal carcinoma (Cell Line: BT-549) [4]
Lenalidomide + Uracil mustard DCUSB4P Lenalidomide Malignant melanoma (Cell Line: LOX IMVI) [5]
Raloxifene + Uracil mustard DCBZFEP Raloxifene Renal cell carcinoma (Cell Line: SN12C) [3]
Raloxifene + Uracil mustard DCXG0R5 Raloxifene Malignant melanoma (Cell Line: UACC62) [5]
Ruxolitinib + Uracil mustard DCSVVHE Ruxolitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Ruxolitinib + Uracil mustard DC01PP6 Ruxolitinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Ruxolitinib + Uracil mustard DCAODFZ Ruxolitinib Glioma (Cell Line: SF-295) [3]
Ruxolitinib + Uracil mustard DCAKPCJ Ruxolitinib Colon carcinoma (Cell Line: KM12) [4]
Ruxolitinib + Uracil mustard DC72N8X Ruxolitinib Adenocarcinoma (Cell Line: DU-145) [5]
Ruxolitinib + Uracil mustard DC6K9N1 Ruxolitinib Adenocarcinoma (Cell Line: NCIH23) [5]
Ruxolitinib + Uracil mustard DCKGV99 Ruxolitinib Lung adenocarcinoma (Cell Line: EKVX) [5]
Ruxolitinib + Uracil mustard DC9WUDT Ruxolitinib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Ruxolitinib + Uracil mustard DCTQACX Ruxolitinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Trifluridine + Uracil mustard DC39HU4 Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Uracil mustard DCNHSY6 Trifluridine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Trifluridine + Uracil mustard DCADJ6I Trifluridine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Trifluridine + Uracil mustard DCKJWN7 Trifluridine Glioma (Cell Line: SF-295) [3]
Trifluridine + Uracil mustard DCM7XQ4 Trifluridine Colon carcinoma (Cell Line: KM12) [4]
Trifluridine + Uracil mustard DCT7NR5 Trifluridine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Trifluridine + Uracil mustard DC1I0MX Trifluridine Malignant melanoma (Cell Line: LOX IMVI) [5]
Uracil mustard + Mechlorethamine DCFEL8F Mechlorethamine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Picoplatin DCOCD0V Picoplatin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Hepzato DCCGCYQ Hepzato Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Hepzato DCY8KG7 Hepzato Chronic myelogenous leukemia (Cell Line: K-562) [3]
Uracil mustard + Ixabepilone DCE8RHF Ixabepilone Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Ixabepilone DCMCOYR Ixabepilone Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Ixabepilone DC8KJHD Ixabepilone Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Dactinomycin DCI7ARI Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Dactinomycin DCKH97W Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Dactinomycin DCI7VB8 Dactinomycin Astrocytoma (Cell Line: U251) [3]
Uracil mustard + Dactinomycin DCBA8TF Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Dactinomycin DCZ1XFD Dactinomycin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Uracil mustard + Dactinomycin DCI7MT7 Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Lapatinib DCLDPII Lapatinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Lapatinib DCQ01OJ Lapatinib Astrocytoma (Cell Line: SNB-19) [3]
Uracil mustard + Lapatinib DC4UM7Y Lapatinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Uracil mustard + PMID28460551-Compound-2 DCN9XFT PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + PMID28460551-Compound-2 DCJQ56D PMID28460551-Compound-2 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + PMID28460551-Compound-2 DCMVI9G PMID28460551-Compound-2 Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Methotrexate DCHM14G Methotrexate Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Methotrexate DCL7JUM Methotrexate Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Uracil mustard + Methotrexate DCV8F0H Methotrexate Glioma (Cell Line: SF-295) [3]
Uracil mustard + Methotrexate DC2CEIV Methotrexate Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Vemurafenib DCY7QVY Vemurafenib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Plicamycin DCCL81S Plicamycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Plicamycin DCY670S Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Plicamycin DCIBA6X Plicamycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Plicamycin DCG17VQ Plicamycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Nilotinib DCDFZ8Q Nilotinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Nilotinib DC1ZCOW Nilotinib Glioblastoma (Cell Line: SNB-75) [3]
Uracil mustard + Nilotinib DCPBSRF Nilotinib Glioma (Cell Line: SF-295) [3]
Uracil mustard + Thioguanine DCU0BGK Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Thioguanine DCJ7O5G Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Thioguanine DC5XSIZ Thioguanine Astrocytoma (Cell Line: SNB-19) [3]
Uracil mustard + Thioguanine DCFIUMX Thioguanine Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Uracil mustard + Thioguanine DCQ1OP1 Thioguanine Glioma (Cell Line: SF-295) [3]
Uracil mustard + Thioguanine DC3OHS7 Thioguanine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Triapine DC5TFG6 Triapine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Triapine DCRTOH8 Triapine Astrocytoma (Cell Line: SNB-19) [3]
Uracil mustard + Triapine DCTENRU Triapine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + 10-hydroxycamptothecin DC9E5ES 10-hydroxycamptothecin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Topetecan DC7WOYW Topetecan Astrocytoma (Cell Line: U251) [3]
Uracil mustard + Topetecan DCWAR28 Topetecan Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Pralatrexate DCIVJE4 Pralatrexate Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Pralatrexate DCQ4LCN Pralatrexate Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Pralatrexate DCXYF3U Pralatrexate Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Terameprocol DC583VM Terameprocol Astrocytoma (Cell Line: SNB-19) [3]
Uracil mustard + Ifosfamide DCA1T71 Ifosfamide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Docetaxel DCL68E1 Docetaxel Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Raloxifene DCZPGXL Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Raloxifene DCG71XR Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Raloxifene DCBQOMW Raloxifene Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Bendamustine hydrochloride DCUDGLH Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Bendamustine hydrochloride DCL4PCO Bendamustine hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Bendamustine hydrochloride DCL956D Bendamustine hydrochloride Chronic myelogenous leukemia (Cell Line: K-562) [3]
Uracil mustard + Bendamustine hydrochloride DCNWNJG Bendamustine hydrochloride Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Sirolimus DCF6J1C Sirolimus Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Sirolimus DCBIUTL Sirolimus Glioma (Cell Line: SF-268) [3]
Uracil mustard + Mitomycin DC8KSSZ Mitomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Mitomycin DCJNE40 Mitomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Mitomycin DC8HNEY Mitomycin Astrocytoma (Cell Line: SNB-19) [3]
Uracil mustard + Mitomycin DCYUYKH Mitomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Mitomycin DC1JAME Mitomycin Glioblastoma (Cell Line: SNB-75) [3]
Uracil mustard + Mitomycin DCMAMZ9 Mitomycin Glioma (Cell Line: SF-295) [3]
Uracil mustard + Mitomycin DCOZUJY Mitomycin Glioma (Cell Line: SF-268) [3]
Uracil mustard + Mitomycin DCD0YFY Mitomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Mitomycin DCKWADS Mitomycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Vincristine DCNBPTD Vincristine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Vincristine DC3BBSK Vincristine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Vincristine DCUU940 Vincristine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Vincristine DCRYGZ5 Vincristine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Vincristine DC8X84L Vincristine Glioma (Cell Line: SF-295) [3]
Uracil mustard + Vincristine DCYSEXO Vincristine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Arfolitixorin DC74Y0Y Arfolitixorin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Arfolitixorin DCRNPF2 Arfolitixorin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Arfolitixorin DCS4HAJ Arfolitixorin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Uracil mustard + Arfolitixorin DCUMO9B Arfolitixorin Glioma (Cell Line: SF-295) [3]
Uracil mustard + Arfolitixorin DCAQSPC Arfolitixorin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + JNK-IN-8 DCMZT8V JNK-IN-8 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + JNK-IN-8 DCNJL0X JNK-IN-8 Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Idarubicin DCZDDB2 Idarubicin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Imatinib DCZML17 Imatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Imatinib DCESBZG Imatinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Uracil mustard + Bleomycin DCH6FYD Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Bleomycin DC914BL Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Bleomycin DC558DV Bleomycin Glioma (Cell Line: SF-268) [3]
Uracil mustard + Bleomycin DCWS3JF Bleomycin Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Bortezomib DC1HU3P Bortezomib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Bortezomib DCF7AQT Bortezomib Astrocytoma (Cell Line: U251) [3]
Uracil mustard + Bortezomib DC1KJMN Bortezomib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Uracil mustard + Bortezomib DCTFFLN Bortezomib Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Dacarbazine DCHCIFA Dacarbazine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Dacarbazine DCFQZ6O Dacarbazine Astrocytoma (Cell Line: SNB-19) [3]
Uracil mustard + Dacarbazine DCM75OP Dacarbazine Glioma (Cell Line: SF-268) [3]
Uracil mustard + Dacarbazine DCMHXKW Dacarbazine Glioma (Cell Line: SF-295) [3]
Uracil mustard + Dacarbazine DCIYXU0 Dacarbazine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Topotecan DCLEZ56 Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Topotecan DCM689G Topotecan Astrocytoma (Cell Line: SNB-19) [3]
Uracil mustard + Topotecan DCW9PTO Topotecan Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Uracil mustard + Topotecan DCSI7U2 Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Uracil mustard + Topotecan DCS3P7O Topotecan Glioblastoma (Cell Line: SNB-75) [3]
Uracil mustard + Topotecan DCRJFVO Topotecan Glioma (Cell Line: SF-295) [3]
Uracil mustard + Topotecan DCWEVZI Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Topotecan DCERK8S Topotecan Renal cell carcinoma (Cell Line: SN12C) [3]
Uracil mustard + Chlorambucil DCO121Y Chlorambucil Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Chlorambucil DCVW1T6 Chlorambucil Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Chlorambucil DCQ5MS8 Chlorambucil Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Sorafenib DCMW6YH Sorafenib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Sorafenib DCNMTF5 Sorafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Sorafenib DCTOVCX Sorafenib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Sorafenib DCFBDNO Sorafenib Astrocytoma (Cell Line: SNB-19) [3]
Uracil mustard + Sorafenib DCW1Y1K Sorafenib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Sorafenib DC0K17X Sorafenib Glioma (Cell Line: SF-295) [3]
Uracil mustard + Romidepsin DCH0I78 Romidepsin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Uracil mustard + Romidepsin DCYC81L Romidepsin Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Uracil mustard + Romidepsin DCNJZ9P Romidepsin Glioblastoma (Cell Line: SNB-75) [3]
Uracil mustard + Pomalidomide DC2DEA8 Pomalidomide Glioma (Cell Line: SF-295) [3]
Uracil mustard + Vinflunine DCUWWPU Vinflunine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Vinflunine DCM83QA Vinflunine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Vinflunine DCWDOI2 Vinflunine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Uracil mustard + Vinflunine DC604FK Vinflunine Glioblastoma (Cell Line: SNB-75) [3]
Uracil mustard + Vinflunine DCPV76R Vinflunine Glioma (Cell Line: SF-295) [3]
Uracil mustard + Vinflunine DC7X7SD Vinflunine Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Taxol DC24NW2 Taxol Glioma (Cell Line: SF-268) [3]
Uracil mustard + Taxol DCGQUQJ Taxol Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Taxol DCVUIOD Taxol Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Fludarabine DC893PP Fludarabine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Fludarabine DC7WPAR Fludarabine Glioma (Cell Line: SF-295) [3]
Uracil mustard + Fludarabine DCA6BXQ Fludarabine Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Uracil mustard + Aminolevulinic Acid Hydrochloride DC6U40G Aminolevulinic Acid Hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Aminolevulinic Acid Hydrochloride DCCJRH2 Aminolevulinic Acid Hydrochloride Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Estramustine DCKNE5Q Estramustine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Busulfan DC3SHRL Busulfan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Uracil mustard + Busulfan DCYXYP5 Busulfan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Uracil mustard + Busulfan DCUF607 Busulfan Anaplastic large cell lymphoma (Cell Line: SR) [3]
Uracil mustard + Busulfan DCDNVUW Busulfan Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Uracil mustard + Dasatinib DCPBKJE Dasatinib Astrocytoma (Cell Line: SNB-19) [3]
Uracil mustard + Dasatinib DCYTCOL Dasatinib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Uracil mustard + Dasatinib DCNGRAU Dasatinib Glioblastoma (Cell Line: SNB-75) [3]
Uracil mustard + Dasatinib DCYBCXO Dasatinib Glioma (Cell Line: SF-539) [3]
Uracil mustard + Dasatinib DCHF70E Dasatinib Glioma (Cell Line: SF-295) [3]
Uracil mustard + Dactinomycin DC8E3SE Dactinomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Uracil mustard + Dactinomycin DCAM18M Dactinomycin Carcinoma (Cell Line: RXF 393) [4]
Uracil mustard + Dactinomycin DC9MHVZ Dactinomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Uracil mustard + Dactinomycin DCZEBJD Dactinomycin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Uracil mustard + Dactinomycin DCT7N5L Dactinomycin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Uracil mustard + PMID28460551-Compound-2 DCK9SI5 PMID28460551-Compound-2 Carcinoma (Cell Line: RXF 393) [4]
Uracil mustard + PMID28460551-Compound-2 DC0WEDU PMID28460551-Compound-2 Carcinoma (Cell Line: MCF7) [4]
Uracil mustard + PMID28460551-Compound-2 DC9MY9F PMID28460551-Compound-2 Colon carcinoma (Cell Line: KM12) [4]
Uracil mustard + Plicamycin DCI9L3V Plicamycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Uracil mustard + Plicamycin DCASNPD Plicamycin Carcinoma (Cell Line: RXF 393) [4]
Uracil mustard + Plicamycin DCYH7VL Plicamycin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Uracil mustard + Thioguanine DCMISZF Thioguanine Carcinoma (Cell Line: RXF 393) [4]
Uracil mustard + Pralatrexate DCUS4D5 Pralatrexate Colon adenocarcinoma (Cell Line: COLO 205) [4]
Uracil mustard + Sirolimus DCUNJI5 Sirolimus Colon adenocarcinoma (Cell Line: COLO 205) [4]
Uracil mustard + Mitomycin DC4SN0C Mitomycin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Uracil mustard + Vincristine DCIDK4A Vincristine Colon adenocarcinoma (Cell Line: COLO 205) [4]
Uracil mustard + Altretamine DCQNSVR Altretamine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Uracil mustard + Bleomycin DCQHQN1 Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [4]
Uracil mustard + Bortezomib DCW71UK Bortezomib Colon adenocarcinoma (Cell Line: COLO 205) [4]
Uracil mustard + Topotecan DCKJQDA Topotecan Colon adenocarcinoma (Cell Line: COLO 205) [4]
Uracil mustard + Topotecan DCQRC15 Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Uracil mustard + Romidepsin DCB2HBL Romidepsin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Uracil mustard + Romidepsin DCZYDGE Romidepsin Invasive ductal carcinoma (Cell Line: BT-549) [4]
Uracil mustard + Aminolevulinic Acid Hydrochloride DCAUJSW Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [4]
Uracil mustard + Busulfan DC12MFM Busulfan Colon adenocarcinoma (Cell Line: COLO 205) [4]
Uracil mustard + Mechlorethamine DCMGPF4 Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Uracil mustard + Mechlorethamine DCZWWHF Mechlorethamine Malignant melanoma (Cell Line: LOX IMVI) [5]
Uracil mustard + Hepzato DCYPXGR Hepzato Adenocarcinoma (Cell Line: DU-145) [5]
Uracil mustard + Hepzato DC03GN0 Hepzato Adenocarcinoma (Cell Line: HCT116) [5]
Uracil mustard + Ixabepilone DCJG6SL Ixabepilone Adenocarcinoma (Cell Line: NCIH23) [5]
Uracil mustard + Dactinomycin DCNWC8U Dactinomycin Adenocarcinoma (Cell Line: HCT116) [5]
Uracil mustard + Dactinomycin DCKOI33 Dactinomycin Adenocarcinoma (Cell Line: HCC-2998) [5]
Uracil mustard + Dactinomycin DCX8GI8 Dactinomycin Adenocarcinoma (Cell Line: SW-620) [5]
Uracil mustard + Dactinomycin DCUCD9K Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Uracil mustard + Dactinomycin DCK9RTT Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Uracil mustard + Dactinomycin DC07LA1 Dactinomycin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Uracil mustard + Dactinomycin DC67VL9 Dactinomycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Uracil mustard + Dactinomycin DCLG0FN Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Uracil mustard + Dactinomycin DC6MVUN Dactinomycin Malignant melanoma (Cell Line: LOX IMVI) [5]
Uracil mustard + Dactinomycin DCFR0SO Dactinomycin Melanoma (Cell Line: MALME-3M) [5]
Uracil mustard + Dactinomycin DCJ94X4 Dactinomycin Melanoma (Cell Line: SK-MEL-2) [5]
Uracil mustard + Dactinomycin DC8V3X9 Dactinomycin Melanoma (Cell Line: UACC-257) [5]
Uracil mustard + DFN-15 DCCCMD1 DFN-15 Lung adenocarcinoma (Cell Line: EKVX) [5]
Uracil mustard + Lapatinib DC8DKVH Lapatinib Adenocarcinoma (Cell Line: DU-145) [5]
Uracil mustard + Lapatinib DC1GCYU Lapatinib Adenocarcinoma (Cell Line: A549) [5]
Uracil mustard + Lapatinib DCH99M6 Lapatinib Adenocarcinoma (Cell Line: HCT-15) [5]
Uracil mustard + Lapatinib DCKHEBU Lapatinib Lung adenocarcinoma (Cell Line: EKVX) [5]
Uracil mustard + PMID28460551-Compound-2 DCZKZPT PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: EKVX) [5]
Uracil mustard + PMID28460551-Compound-2 DCAOGE9 PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Uracil mustard + PMID28460551-Compound-2 DCGOE32 PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Uracil mustard + Crizotinib DC3CF5F Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Uracil mustard + Cyclophosphamide DCRYSCZ Cyclophosphamide High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Uracil mustard + Cyclophosphamide DCESSVD Cyclophosphamide Melanoma (Cell Line: SK-MEL-2) [5]
Uracil mustard + LIAROZOLE DCGPQSZ LIAROZOLE Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Uracil mustard + Isoniazid DCNFE0J Isoniazid High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Uracil mustard + Vemurafenib DCGJD01 Vemurafenib Adenocarcinoma (Cell Line: HT29) [5]
Uracil mustard + Plicamycin DCVW42Y Plicamycin Adenocarcinoma (Cell Line: HCC-2998) [5]
Uracil mustard + Plicamycin DCW3EXO Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Uracil mustard + Plicamycin DCGRHM2 Plicamycin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Uracil mustard + Plicamycin DC6AP8P Plicamycin Malignant melanoma (Cell Line: UACC62) [5]
Uracil mustard + Plicamycin DCP7GNH Plicamycin Melanoma (Cell Line: UACC-257) [5]
Uracil mustard + Nilotinib DCFUZG3 Nilotinib Adenocarcinoma (Cell Line: HCT116) [5]
Uracil mustard + Nilotinib DCHDI0F Nilotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Uracil mustard + Thioguanine DCYZHEC Thioguanine Lung adenocarcinoma (Cell Line: EKVX) [5]
Uracil mustard + Thioguanine DCB126I Thioguanine Melanoma (Cell Line: SK-MEL-2) [5]
Uracil mustard + Triapine DCT1FMA Triapine Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Uracil mustard + Pralatrexate DCZGJNX Pralatrexate Adenocarcinoma (Cell Line: NCIH23) [5]
Uracil mustard + Pralatrexate DCYZ219 Pralatrexate Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Uracil mustard + Pralatrexate DC9H470 Pralatrexate Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Uracil mustard + Terameprocol DCI1P6F Terameprocol Adenocarcinoma (Cell Line: HCT116) [5]
Uracil mustard + Terameprocol DCGYGWT Terameprocol High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Uracil mustard + SCH 727965 DC3C5E3 SCH 727965 Adenocarcinoma (Cell Line: HT29) [5]
Uracil mustard + Ifosfamide DCB50L8 Ifosfamide Adenocarcinoma (Cell Line: HCT116) [5]
Uracil mustard + Bendamustine hydrochloride DCSHQB6 Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [5]
Uracil mustard + Bendamustine hydrochloride DCNFXFN Bendamustine hydrochloride Adenocarcinoma (Cell Line: HT29) [5]
Uracil mustard + Bendamustine hydrochloride DC5MI9A Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT116) [5]
Uracil mustard + Bendamustine hydrochloride DCYP0H1 Bendamustine hydrochloride Adenocarcinoma (Cell Line: HCT-15) [5]
Uracil mustard + Bendamustine hydrochloride DCT0K8M Bendamustine hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Uracil mustard + Bendamustine hydrochloride DCW04KT Bendamustine hydrochloride Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Uracil mustard + Bendamustine hydrochloride DC8529N Bendamustine hydrochloride Melanoma (Cell Line: MALME-3M) [5]
Uracil mustard + Sirolimus DCHN0M2 Sirolimus Melanoma (Cell Line: SK-MEL-2) [5]
Uracil mustard + Mitomycin DCQKXVO Mitomycin Adenocarcinoma (Cell Line: SW-620) [5]
Uracil mustard + Mitomycin DCKNJVJ Mitomycin Adenocarcinoma (Cell Line: HT29) [5]
Uracil mustard + Mitomycin DC4GJRW Mitomycin Adenocarcinoma (Cell Line: HCT-15) [5]
Uracil mustard + Mitomycin DC6YRI9 Mitomycin Adenocarcinoma (Cell Line: HCT116) [5]
Uracil mustard + Mitomycin DCTS7RH Mitomycin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Uracil mustard + Mitomycin DCJCHMD Mitomycin Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Uracil mustard + Mitomycin DCMS331 Mitomycin Lung adenocarcinoma (Cell Line: EKVX) [5]
Uracil mustard + Mitomycin DCI34Z6 Mitomycin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Uracil mustard + SY-1425 DCG571P SY-1425 Melanoma (Cell Line: MALME-3M) [5]
Uracil mustard + Vincristine DC6TTV8 Vincristine Adenocarcinoma (Cell Line: DU-145) [5]
Uracil mustard + Vincristine DCO5YRY Vincristine Adenocarcinoma (Cell Line: A549) [5]
Uracil mustard + Vincristine DCL5TJG Vincristine Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Uracil mustard + Vincristine DCBX6XL Vincristine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Uracil mustard + Vincristine DCDJ2MM Vincristine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Uracil mustard + Arfolitixorin DC4C1XF Arfolitixorin Malignant melanoma (Cell Line: LOX IMVI) [5]
Uracil mustard + Arfolitixorin DCRVOWM Arfolitixorin Melanoma (Cell Line: SK-MEL-2) [5]
Uracil mustard + Altretamine DC5KJX6 Altretamine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Uracil mustard + Imatinib DCRS2CH Imatinib Adenocarcinoma (Cell Line: NCIH23) [5]
Uracil mustard + Imatinib DC4DIOX Imatinib Adenocarcinoma (Cell Line: HCT-15) [5]
Uracil mustard + Imatinib DCKIPAO Imatinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Uracil mustard + Bleomycin DC3C860 Bleomycin Adenocarcinoma (Cell Line: HCT-15) [5]
Uracil mustard + Bleomycin DCZ872N Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Uracil mustard + Bleomycin DC1T8BQ Bleomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Uracil mustard + Bortezomib DC6R9GE Bortezomib Adenocarcinoma (Cell Line: A549) [5]
Uracil mustard + Bortezomib DCINXZL Bortezomib Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Uracil mustard + Bortezomib DCHD6KO Bortezomib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Uracil mustard + Dacarbazine DCOG94U Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Uracil mustard + Dacarbazine DC2MUIH Dacarbazine Lung adenocarcinoma (Cell Line: EKVX) [5]
Uracil mustard + Dacarbazine DCQYK7O Dacarbazine Melanoma (Cell Line: SK-MEL-2) [5]
Uracil mustard + Dacarbazine DCB9CYN Dacarbazine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Uracil mustard + Topotecan DCQQA7A Topotecan Adenocarcinoma (Cell Line: OVCAR3) [5]
Uracil mustard + Topotecan DCOR628 Topotecan Adenocarcinoma (Cell Line: A549) [5]
Uracil mustard + Topotecan DCKR08Y Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Uracil mustard + Topotecan DCB2HQT Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Uracil mustard + Topotecan DCAQWNQ Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Uracil mustard + Topotecan DCLVV4D Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Uracil mustard + Topotecan DCROFWZ Topotecan Lung adenocarcinoma (Cell Line: EKVX) [5]
Uracil mustard + Topotecan DCFLULP Topotecan Malignant melanoma (Cell Line: LOX IMVI) [5]
Uracil mustard + Topotecan DC5ZTKW Topotecan Melanoma (Cell Line: MALME-3M) [5]
Uracil mustard + Topotecan DC1PNPK Topotecan Melanoma (Cell Line: UACC-257) [5]
Uracil mustard + Topotecan DCTU1V8 Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Uracil mustard + Topotecan DC0VX0V Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Uracil mustard + Topotecan DCR72TA Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Uracil mustard + Topotecan DCAE3ZW Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Uracil mustard + Chlorambucil DCBX4CU Chlorambucil Adenocarcinoma (Cell Line: HCT116) [5]
Uracil mustard + Sorafenib DCTEA79 Sorafenib Adenocarcinoma (Cell Line: DU-145) [5]
Uracil mustard + Sorafenib DCBTE3Q Sorafenib Adenocarcinoma (Cell Line: NCIH23) [5]
Uracil mustard + Sorafenib DCP7Y8S Sorafenib Adenocarcinoma (Cell Line: A549) [5]
Uracil mustard + Sorafenib DCKY54S Sorafenib Adenocarcinoma (Cell Line: HT29) [5]
Uracil mustard + Sorafenib DCJO529 Sorafenib Adenocarcinoma (Cell Line: HCT116) [5]
Uracil mustard + Romidepsin DCF26R2 Romidepsin Adenocarcinoma (Cell Line: DU-145) [5]
Uracil mustard + Romidepsin DCRWHDH Romidepsin Adenocarcinoma (Cell Line: A549) [5]
Uracil mustard + Romidepsin DC0NKSI Romidepsin Adenocarcinoma (Cell Line: HT29) [5]
Uracil mustard + Romidepsin DCQENWB Romidepsin Adenocarcinoma (Cell Line: SW-620) [5]
Uracil mustard + Romidepsin DCN35B3 Romidepsin Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Uracil mustard + Romidepsin DCUEQ7P Romidepsin Lung adenocarcinoma (Cell Line: EKVX) [5]
Uracil mustard + Romidepsin DCSTN2D Romidepsin Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Uracil mustard + Romidepsin DCZXJT6 Romidepsin Melanoma (Cell Line: MALME-3M) [5]
Uracil mustard + Romidepsin DC1DYYS Romidepsin Melanoma (Cell Line: UACC-257) [5]
Uracil mustard + Romidepsin DCO84QV Romidepsin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Uracil mustard + Romidepsin DCSYUEO Romidepsin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Uracil mustard + Pomalidomide DCQGJCG Pomalidomide High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Uracil mustard + Vinflunine DCE8ASK Vinflunine Adenocarcinoma (Cell Line: DU-145) [5]
Uracil mustard + Vinflunine DCU32DV Vinflunine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Uracil mustard + Mepacrine DCFSZLE Mepacrine Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Uracil mustard + Taxol DCJGFHW Taxol Adenocarcinoma (Cell Line: NCIH23) [5]
Uracil mustard + Fludarabine DCDRTJ3 Fludarabine Adenocarcinoma (Cell Line: DU-145) [5]
Uracil mustard + Fludarabine DCD1JEF Fludarabine Adenocarcinoma (Cell Line: HT29) [5]
Uracil mustard + Fludarabine DCHDG9Q Fludarabine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Uracil mustard + Fludarabine DCEOXYO Fludarabine Malignant melanoma (Cell Line: LOX IMVI) [5]
Uracil mustard + Aminolevulinic Acid Hydrochloride DCSYT2Y Aminolevulinic Acid Hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Uracil mustard + Estramustine DCPVMEB Estramustine Adenocarcinoma (Cell Line: NCIH23) [5]
Uracil mustard + Busulfan DCPR6CS Busulfan High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Uracil mustard + Dasatinib DCXN5AA Dasatinib Adenocarcinoma (Cell Line: HCT116) [5]
Uracil mustard + Dasatinib DCRSSI7 Dasatinib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Uracil mustard + Dasatinib DCTAU5X Dasatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Uracil mustard + Dasatinib DCT7MUE Dasatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Uracil mustard + Dasatinib DC1UK7Y Dasatinib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Uracil mustard + Dasatinib DCBBDX5 Dasatinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Uracil mustard + Dasatinib DC8O86G Dasatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Vandetanib + Uracil mustard DCCO64G Vandetanib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vandetanib + Uracil mustard DCI311E Vandetanib Colon carcinoma (Cell Line: KM12) [4]
Vandetanib + Uracil mustard DCYWWXK Vandetanib Adenocarcinoma (Cell Line: DU-145) [5]
Vandetanib + Uracil mustard DCLB8JR Vandetanib Adenocarcinoma (Cell Line: NCIH23) [5]
Vandetanib + Uracil mustard DCUIPM1 Vandetanib Adenocarcinoma (Cell Line: A549) [5]
Vandetanib + Uracil mustard DC1JE1J Vandetanib Adenocarcinoma (Cell Line: SW-620) [5]
Vandetanib + Uracil mustard DC07BIT Vandetanib Adenocarcinoma (Cell Line: HT29) [5]
Vandetanib + Uracil mustard DC02A63 Vandetanib Adenocarcinoma (Cell Line: HCT-15) [5]
Vandetanib + Uracil mustard DCGSUCD Vandetanib Astrocytoma (Cell Line: SNB-19) [5]
Vandetanib + Uracil mustard DCX3BCR Vandetanib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Vandetanib + Uracil mustard DCB2YG3 Vandetanib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vandetanib + Uracil mustard DCHWOHQ Vandetanib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Vandetanib + Uracil mustard DCSD4RG Vandetanib Glioblastoma (Cell Line: SNB-75) [5]
Vandetanib + Uracil mustard DC6GBZU Vandetanib Glioma (Cell Line: SF-295) [5]
Vandetanib + Uracil mustard DCVM8R0 Vandetanib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Vandetanib + Uracil mustard DCPP9MD Vandetanib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Vandetanib + Uracil mustard DCLY8I5 Vandetanib Lung adenocarcinoma (Cell Line: HOP-62) [5]
Vandetanib + Uracil mustard DCGU6PU Vandetanib Lung adenocarcinoma (Cell Line: EKVX) [5]
Vandetanib + Uracil mustard DC4XV0Z Vandetanib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Vandetanib + Uracil mustard DC81DWQ Vandetanib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vandetanib + Uracil mustard DC7VXIS Vandetanib Melanoma (Cell Line: SK-MEL-2) [5]
Vandetanib + Uracil mustard DCC2CDD Vandetanib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Vandetanib + Uracil mustard DCFR8FQ Vandetanib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Vandetanib + Uracil mustard DCZCZGO Vandetanib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Vandetanib + Uracil mustard DCPZCFS Vandetanib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Vandetanib + Uracil mustard DC2UEFW Vandetanib Renal cell carcinoma (Cell Line: SN12C) [5]
Vemurafenib + Uracil mustard DCTCS7T Vemurafenib Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Vemurafenib + Uracil mustard DCMJWFP Vemurafenib Carcinoma (Cell Line: RXF 393) [4]
Vemurafenib + Uracil mustard DC6G37U Vemurafenib Colon carcinoma (Cell Line: KM12) [4]
Vemurafenib + Uracil mustard DCXXYJ1 Vemurafenib Invasive ductal carcinoma (Cell Line: T-47D) [4]
Vemurafenib + Uracil mustard DCUH7HV Vemurafenib Adenocarcinoma (Cell Line: HT29) [5]
Vemurafenib + Uracil mustard DCXJWF5 Vemurafenib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Vemurafenib + Uracil mustard DC17ZFO Vemurafenib Astrocytoma (Cell Line: SNB-19) [5]
Vemurafenib + Uracil mustard DCDC4JX Vemurafenib Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Vemurafenib + Uracil mustard DC06JX4 Vemurafenib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Vemurafenib + Uracil mustard DCR5GOS Vemurafenib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vemurafenib + Uracil mustard DCL97SP Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Vemurafenib + Uracil mustard DCZC3GG Vemurafenib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Vemurafenib + Uracil mustard DCKRXJ2 Vemurafenib Malignant melanoma (Cell Line: UACC62) [5]
Vemurafenib + Uracil mustard DCE15QU Vemurafenib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vemurafenib + Uracil mustard DC6YLPD Vemurafenib Melanoma (Cell Line: SK-MEL-2) [5]
Vemurafenib + Uracil mustard DCCJA8M Vemurafenib Melanoma (Cell Line: UACC-257) [5]
Vemurafenib + Uracil mustard DCA6H18 Vemurafenib Melanoma (Cell Line: MALME-3M) [5]
Vemurafenib + Uracil mustard DCDXBUI Vemurafenib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Vemurafenib + Uracil mustard DCFBDE9 Vemurafenib Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Vismodegib + Uracil mustard DCQQHO5 Vismodegib Colon carcinoma (Cell Line: KM12) [4]
Vismodegib + Uracil mustard DCASZAK Vismodegib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vismodegib + Uracil mustard DCEOPJO Vismodegib Adenocarcinoma (Cell Line: DU-145) [5]
Vismodegib + Uracil mustard DCNDGM2 Vismodegib Adenocarcinoma (Cell Line: NCIH23) [5]
Vismodegib + Uracil mustard DCHQQU9 Vismodegib Adenocarcinoma (Cell Line: HCT116) [5]
Vismodegib + Uracil mustard DC6J8Z2 Vismodegib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Vismodegib + Uracil mustard DC1TGRA Vismodegib Astrocytoma (Cell Line: U251) [5]
Vismodegib + Uracil mustard DCOZMV2 Vismodegib Astrocytoma (Cell Line: SNB-19) [5]
Vismodegib + Uracil mustard DC2SEWV Vismodegib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Vismodegib + Uracil mustard DCF0AQS Vismodegib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Vismodegib + Uracil mustard DCWXKAG Vismodegib Glioma (Cell Line: SF-295) [5]
Vismodegib + Uracil mustard DCODUXK Vismodegib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Vismodegib + Uracil mustard DCF0PR5 Vismodegib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Vismodegib + Uracil mustard DCHBA1X Vismodegib Lung adenocarcinoma (Cell Line: EKVX) [5]
Vismodegib + Uracil mustard DCDEN0E Vismodegib Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Vismodegib + Uracil mustard DCOY1E8 Vismodegib Lung adenocarcinoma (Cell Line: NCI-H522) [5]
Vismodegib + Uracil mustard DC2TZAN Vismodegib Malignant melanoma (Cell Line: LOX IMVI) [5]
Vismodegib + Uracil mustard DCSR5JR Vismodegib Malignant melanoma (Cell Line: UACC62) [5]
Vismodegib + Uracil mustard DCBLFU2 Vismodegib Melanoma (Cell Line: SK-MEL-2) [5]
Vismodegib + Uracil mustard DCN5Q3Y Vismodegib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Vismodegib + Uracil mustard DCHA8A8 Vismodegib Prostate carcinoma (Cell Line: PC-3) [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 642 DrugCom(s)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7621).
2 Uracil mustard FDA Label
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
5 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.